23rd July 2010 - A paper titled “Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes” will be published in the August issue of Diabetes.
Diabetes is the reference journal for the physiology and pathophysiology of diabetes mellitus. The latest impact factor for Diabetes is 8.261, it is ranked 3rd of 92 publications in the field of endocrinology/metabolism and 2nd among journals publishing original research in that field.
The paper presents results of preclinical research conducted with calcium dobesilate - the active principle of Doxium® by a research team of the AIBILI centre in Coimbra, Portugal in collaboration with OM Pharma... OM Pharma's Press Release -
Blog Archive
-
▼
2010
(70)
-
▼
July
(7)
- OM Pharma : New article published in Diabetes pres...
- Prodigy : syringe-filling system for blind and low...
- Forest Laboratories and Gedeon Richter : Results f...
- Johnson & Johnson Pharmaceutical Research & Develo...
- Novo Nordisk : Victoza® to be launched in Japan
- Vitae Pharmaceuticals Receives $14 Million Milesto...
- Servier : Launch of IMIDIA, an Innovative Medicine...
-
▼
July
(7)